218 related articles for article (PubMed ID: 19272388)
1. Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.
Akazawa Y; Mott JL; Bronk SF; Werneburg NW; Kahraman A; Guicciardi ME; Meng XW; Kohno S; Shah VH; Kaufmann SH; McNiven MA; Gores GJ
Gastroenterology; 2009 Jun; 136(7):2365-2376.e1-7. PubMed ID: 19272388
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein-induced lysosomal translocation of proapoptotic effectors is mediated by phosphofurin acidic cluster sorting protein-2 (PACS-2).
Werneburg NW; Bronk SF; Guicciardi ME; Thomas L; Dikeakos JD; Thomas G; Gores GJ
J Biol Chem; 2012 Jul; 287(29):24427-37. PubMed ID: 22645134
[TBL] [Abstract][Full Text] [Related]
3. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
Zhang Y; Zhang B
Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
[TBL] [Abstract][Full Text] [Related]
4. Combination of TRAIL with bortezomib shifted apoptotic signaling from DR4 to DR5 death receptor by selective internalization and degradation of DR4.
Bychkov ML; Gasparian ME; Dolgikh DA; Kirpichnikov MP
PLoS One; 2014; 9(10):e109756. PubMed ID: 25310712
[TBL] [Abstract][Full Text] [Related]
5. cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis.
Guicciardi ME; Bronk SF; Werneburg NW; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1337-46. PubMed ID: 17272514
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
[TBL] [Abstract][Full Text] [Related]
7. TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5.
Lemke J; Noack A; Adam D; Tchikov V; Bertsch U; Röder C; Schütze S; Wajant H; Kalthoff H; Trauzold A
J Mol Med (Berl); 2010 Jul; 88(7):729-40. PubMed ID: 20354842
[TBL] [Abstract][Full Text] [Related]
8. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
Yang JF; Cao JG; Tian L; Liu F
Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
[TBL] [Abstract][Full Text] [Related]
10. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
11. GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis.
Kurita S; Mott JL; Almada LL; Bronk SF; Werneburg NW; Sun SY; Roberts LR; Fernandez-Zapico ME; Gores GJ
Oncogene; 2010 Aug; 29(34):4848-58. PubMed ID: 20562908
[TBL] [Abstract][Full Text] [Related]
12. Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.
Mahalingam D; Natoni A; Keane M; Samali A; Szegezdi E
Br J Cancer; 2010 Feb; 102(4):754-64. PubMed ID: 20087343
[TBL] [Abstract][Full Text] [Related]
13. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
Jayasooriya RG; Choi YH; Hyun JW; Kim GY
Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
[TBL] [Abstract][Full Text] [Related]
14. An HPLC method associated with a thermodynamic analysis to compare the binding of TRAIL and its nanovectorized form to death receptors DR4 and DR5 and their relationship to cytotoxicity.
Guillaume YC; Lethier L; André C
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():142-148. PubMed ID: 27750195
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle.
Ren YG; Wagner KW; Knee DA; Aza-Blanc P; Nasoff M; Deveraux QL
Mol Biol Cell; 2004 Nov; 15(11):5064-74. PubMed ID: 15356269
[TBL] [Abstract][Full Text] [Related]
16. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
[TBL] [Abstract][Full Text] [Related]
18. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG
World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins.
Werneburg NW; Guicciardi ME; Bronk SF; Kaufmann SH; Gores GJ
J Biol Chem; 2007 Sep; 282(39):28960-28970. PubMed ID: 17686764
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of soluble TRAIL in human hepatocellular carcinoma.
He S; Chen Y; Chen X; Zhao Y; Wang H; Zhang W; Wang S
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):51-4. PubMed ID: 15934308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
